Chimerix, Inc. is a biopharmaceutical discoverers and commercializes oral antiviral therapeutics. The Company develops novel antiviral therapeutics with the potential to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix operates in the United States.
2505 Meridian Parkway
Durham, NC 27713